Literature DB >> 17916446

Developmental changes of FOXP3-expressing CD4+CD25+ regulatory T cells and their impairment in patients with FOXP3 gene mutations.

Tatsuya Fuchizawa1, Yuichi Adachi, Yasunori Ito, Hiroyuki Higashiyama, Hirokazu Kanegane, Takeshi Futatani, Ichiro Kobayashi, Yoshiro Kamachi, Tatsuo Sakamoto, Ikuya Tsuge, Hiroshi Tanaka, Alison H Banham, Hans D Ochs, Toshio Miyawaki.   

Abstract

FOXP3 is required for the generation and function of CD4(+)CD25(+) regulatory T (Treg) cells. To elucidate the biological role of Treg cells, we used a monoclonal anti-FOXP3 antibody to examine the frequencies of Treg cells during child development. The percentages of CD4(+)CD25(+)FOXP3(+) T cells were constant shortly from after birth through adulthood. CD4(+)CD25(+)FOXP3(+) T cells in cord blood showed the naive CD45RA(+)CD45RO(-) phenotype, whereas adult CD4(+)CD25(+)FOXP3(+) T cells expressed mostly the memory CD45RA(-)CD45RO(+) phenotype. The age-dependent dominance of memory CD4(+)CD25(+)FOXP3(+) T cells implies functional differences between naive and memory Treg cells. Notably, four patients with FOXP3 gene mutations revealed a paucity of CD4(+)CD25(+)FOXP3(+) T cells. Importantly, one patient with a frame shift mutation, who showed typical symptoms of IPEX (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), exhibited marked T cell activation, whereas others with missense mutations, who were clinically milder, did not. This observation suggests a possible genotype-phenotype correlation in IPEX.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916446     DOI: 10.1016/j.clim.2007.08.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  17 in total

1.  Extremely Early Onset IPEX Syndrome Caused by a Novel Small Exonic Deletion in FOXP3.

Authors:  Erika Smith; Siri Atma W Greeley; Honggang Ye; Troy R Torgerson; Reed Dimmitt; Prescott Atkinson; Joseph Philips; Frederick Goldman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

2.  FOXP3 exon 2 controls Treg stability and autoimmunity.

Authors:  Jianguang Du; Qun Wang; Shuangshuang Yang; Si Chen; Yongyao Fu; Sabine Spath; Phillip Domeier; David Hagin; Stephanie Anover-Sombke; Maya Haouili; Sheng Liu; Jun Wan; Lei Han; Juli Liu; Lei Yang; Neel Sangani; Yujing Li; Xiongbin Lu; Sarath Chandra Janga; Mark H Kaplan; Troy R Torgerson; Steven F Ziegler; Baohua Zhou
Journal:  Sci Immunol       Date:  2022-06-24

3.  Minimal change nephrotic syndrome associated with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome.

Authors:  Yuya Hashimura; Kandai Nozu; Hirokazu Kanegane; Toshio Miyawaki; Akira Hayakawa; Norishige Yoshikawa; Koichi Nakanishi; Minoru Takemoto; Kazumoto Iijima; Masafumi Matsuo
Journal:  Pediatr Nephrol       Date:  2009-02-03       Impact factor: 3.714

Review 4.  FOXP3: genetic and epigenetic implications for autoimmunity.

Authors:  Hiroto Katoh; Pan Zheng; Yang Liu
Journal:  J Autoimmun       Date:  2013-01-11       Impact factor: 7.094

5.  Lack of CD4⁺CD25⁺FOXP3⁺ regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease.

Authors:  Yu Hirabayashi; Yoshiyuki Takahashi; Yinyan Xu; Kazuyuki Akane; Itzel Bustos Villalobos; Yusuke Okuno; Shinji Hasegawa; Hideki Muramatsu; Asahito Hama; Taichi Kato; Seiji Kojima
Journal:  Eur J Pediatr       Date:  2013-01-23       Impact factor: 3.183

6.  Significant augmentation of regulatory T cell numbers occurs during the early neonatal period.

Authors:  S Hayakawa; N Ohno; S Okada; M Kobayashi
Journal:  Clin Exp Immunol       Date:  2017-08-10       Impact factor: 4.330

Review 7.  Autoimmunity and Primary Immunodeficiency Disorders.

Authors:  Eric Allenspach; Troy R Torgerson
Journal:  J Clin Immunol       Date:  2016-05-23       Impact factor: 8.317

8.  Thymopoiesis and regulatory T cells in healthy children and adolescents.

Authors:  Maria Izabel Arismendi; Esper Georges Kallás; Bianca Almeida Natali dos Santos; Magda Maria Sales Carneiro-Sampaio; Cristiane Kayser
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

9.  Clinical heterogeneity in patients with FOXP3 mutations presenting with permanent neonatal diabetes.

Authors:  Oscar Rubio-Cabezas; Jayne A L Minton; Richard Caswell; Julian P Shield; Dorothee Deiss; Zdenek Sumnik; Amely Cayssials; Mathias Herr; Anja Loew; Vaughan Lewis; Sian Ellard; Andrew T Hattersley
Journal:  Diabetes Care       Date:  2008-10-17       Impact factor: 17.152

10.  Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity.

Authors:  Federica Barzaghi; Laura Passerini; Rosa Bacchetta
Journal:  Front Immunol       Date:  2012-07-31       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.